GlassScriptPhysician profile
Amy L Damiani
NPI 1174626170
$397.03
in general payments reported to CMS, 2019-2025
14 companies · $311 in 2025
The $311 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.06 · 2020: $16.72 · 2023: $29.12 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $340.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $80.23 | 2025 | Ozempic, Wegovy |
| Lilly USA, LLC | $48.50 | 2025 | Jardiance, Mounjaro, Zepbound |
| Medtronic Minimed, INC. | $43.20 | 2019-2020 | |
| Verona Pharma, INC. | $33.55 | 2025 | Ohtuvayre |
| Medtronic, INC. | $29.12 | 2023 | Minimed 780g |
| Boston Scientific Corporation | $26.36 | 2025 | Watchman Flx |
| Exact Sciences Corporation | $20.51 | 2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.34 | 2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $18.04 | 2025 | |
| Abbvie INC. | $17.69 | 2025 | |
| Amgen INC. | $16.93 | 2025 | Otezla, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.61 | 2025 | Xifaxan |
| Pfizer INC. | $14.37 | 2025 | |
| Grifols USA, LLC | $13.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Damiani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.